CAS Number 887289-02-3 ChemSpider 23320245 3D model (Jmol) Interactive image | PubChem CID 24763642 Formula C20H23F4N3O Molar mass 397.409 g/mol | |
 | ||
CBS-0550 is a drug developed by Taisho Pharmaceutical, which acts as a potent and selective cannabinoid CB2 receptor agonist, with 1400x selectivity for CB2 over the related CB1 receptor. Unlike most cannabinoid agonists, CBS-0550 has good solubility in water, and in animal studies it was found to produce analgesic and anti-hyperalgesic effects. A number of related compounds have been developed with similar properties.
References
CBS-0550 Wikipedia(Text) CC BY-SA